











Gene therapies costing $2 million or more per patient can cure diseases like sickle cell with a single treatment, but America's healthcare system lacks the infrastructure and financing models to pay for these cures. While the high cost reflects decades of value concentrated into
The AI industry has long operated on the assumption that bigger models are more powerful and therefore superior. However, mounting costs are forcing users to reconsider smaller, cheaper AI models. This cost-conscious shift in model selection is new and could significantly impact










